Ru K - Search Results

1

Multiplex ligation-dependent probe amplification assay identifies additional copy number changes compared with R-band karyotype and provide more accuracy prognostic information in myelodysplastic syndromes.

Wang J, Ai X, Qin T, Xu Z, Zhang Y, Liu J, Li B, Fang L, Zhang H, Pan L, Hu N, Qu S, Cai W, Ru K, Jia Y, Huang G, Xiao Z. Wang J, et al. Among authors: ru k. Oncotarget. 2017 Jan 3;8(1):1603-1612. doi: 10.18632/oncotarget.13688. Oncotarget. 2017. PMID: 27906673 Free PMC article.

2

Specific inhibition of breast cancer cells by antisense poly-DNP-oligoribonucleotides and targeted apoptosis.

Ru K, Taub ML, Wang JH. Ru K, et al. Oncol Res. 1998;10(8):389-97. Oncol Res. 1998. PMID: 10100755

3

[CEBPA gene mutation analysis in acute myeloid leukemia].

Han C, Lin D, Ai XF, Wang F, Sun HY, Wang M, Mi YC, Wang JX, Ru K. Han C, et al. Among authors: ru k. Zhonghua Xue Ye Xue Za Zhi. 2013 Jul;34(7):566-71. doi: 10.3760/cma.j.issn.0253-2727.2013.07.002. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23906447 Chinese.

4

[Significance of BIOMED-2 standardized IG/TCR gene rearrangement detection in paraffin-embedded section in lymphoma diagnosis].

Ai X, Fu Q, Wang J, Zheng Y, Han C, Li Q, Sun Q, Ru K. Ai X, et al. Among authors: ru k. Zhonghua Xue Ye Xue Za Zhi. 2014 Jun;35(6):495-8. doi: 10.3760/cma.j.issn.0253-2727.2014.06.004. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 24985170 Chinese.

5

Heterogeneous chromosome 12p deletion is an independent adverse prognostic factor and resistant to bortezomib-based therapy in multiple myeloma.

Li F, Xu Y, Deng P, Yang Y, Sui W, Jin F, Hao M, Li Z, Zang M, Zhou D, Gu Z, Ru K, Wang J, Cheng T, Qiu L. Li F, et al. Among authors: ru k. Oncotarget. 2015 Apr 20;6(11):9434-44. doi: 10.18632/oncotarget.3319. Oncotarget. 2015. PMID: 25831238 Free PMC article. Clinical Trial.

6

The Prevalence of JAK2, MPL, and CALR Mutations in Chinese Patients With BCR-ABL1-Negative Myeloproliferative Neoplasms.

Lin Y, Liu E, Sun Q, Ma J, Li Q, Cao Z, Wang J, Jia Y, Zhang H, Song Z, Ai X, Shi L, Feng X, Li C, Wang J, Ru K. Lin Y, et al. Among authors: ru k. Am J Clin Pathol. 2015 Jul;144(1):165-71. doi: 10.1309/AJCPALP51XDIXDDV. Am J Clin Pathol. 2015. PMID: 26071474

7

Sequence-based typing identification of a novel HLA-A*33:95 variant in a Chinese family.

Wang XJ, Han C, Zhang Y, Li QH, Ru K. Wang XJ, et al. Among authors: ru k. Tissue Antigens. 2015 Nov;86(5):384. doi: 10.1111/tan.12678. Epub 2015 Sep 28. Tissue Antigens. 2015. PMID: 26411515

8

Detection of recurrent cytogenetic aberrations in multiple myeloma: a comparison between MLPA and iFISH.

Zang M, Zou D, Yu Z, Li F, Yi S, Ai X, Qin X, Feng X, Zhou W, Xu Y, Li Z, Hao M, Sui W, Deng S, Acharya C, Zhao Y, Ru K, Qiu L, An G. Zang M, et al. Among authors: ru k. Oncotarget. 2015 Oct 27;6(33):34276-87. doi: 10.18632/oncotarget.5371. Oncotarget. 2015. PMID: 26416457 Free PMC article.

9

High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survival.

Yi S, Zou D, Li C, Zhong S, Chen W, Li Z, Xiong W, Liu W, Liu E, Cui R, Ru K, Zhang P, Xu Y, An G, Lv R, Qi J, Wang J, Cheng T, Qiu L. Yi S, et al. Among authors: ru k. Oncotarget. 2015 Dec 8;6(39):42362-71. doi: 10.18632/oncotarget.5705. Oncotarget. 2015. PMID: 26517511 Free PMC article.

10

[Application of BIOMED- 2 standardized Ig gene rearrangement system in multiple myeloma].

Ai X, Wang X, Wang B, Chen S, Wang J, Li Q, An G, Ru K. Ai X, et al. Among authors: ru k. Zhonghua Xue Ye Xue Za Zhi. 2015 Nov;36(11):918-21. doi: 10.3760/cma.j.issn.0253-2727.2015.11.006. Zhonghua Xue Ye Xue Za Zhi. 2015. PMID: 26632463 Free PMC article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters